Neuphoria Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2023-12-31 |
|---|---|---|---|
Revenue | $662 | $0 | $0 |
Net Income | -1,943 | -804 | -4,554 |
Net Change In Cash | 662 | 0 | 0 |
Free Cash Flow | -3,358 | -4,433 | -3,945 |
Cash | 4,344 | 8,082 | 10,128 |
Basic Shares | 1,628 | 3,117,662 | 1,924,808 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $181 | $0 |
Net Income | -15,492 | -21,381 | -14,968 | -6,534 |
Net Change In Cash | 0 | 0 | 181 | 0 |
Free Cash Flow | -14,680 | -14,637 | -14,966 | -5,665 |
Cash | 12,608 | 12,103 | 23,089 | 21,412 |
Basic Shares | 2,384,539 | 1,468,735 | 1,353,350 | 1,007,596 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.23 |
2024-09-30 | -$0.003 |
2023-12-31 | -$63.75 |
